Authors

Alessandro Villa, Miami Cancer InstituteFollow

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review

Publication Date

1-1-2025

Content Type

Article

PubMed ID:

39681618

Additional Authors:

Additional authors and institutional affiliations

Citation

Villa, A., Schneider, B. J., Lacchetti, C., Oliver, T. K., & Peterson, D. E. (2025). Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review. British journal of cancer, 132(1), 49–50. https://doi.org/10.1038/s41416-024-02933-y